Seminars in Nuclear Medicine
Volume 39, Issue 3 , Pages 186-194 , May 2009

Selected Interventions in Nuclear Medicine: Gastrointestinal Motor Functions

References 

  1. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138
  2. Camilleri M, Dubois D, Coulie B, et al. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: Results of the US Upper Gastrointestinal Study. Clin Gastroenterol Hepatol. 2005;3:543–552
  3. Lin HC, Prather C, Fisher RS, et al. Measurement of gastrointestinal transit. Dig Dis Sci. 2005;50:989–1004
  4. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: A joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103:753–763
  5. Mariani G, Boni G, Barreca M, et al. Radionuclide gastroesophageal motor studies. J Nucl Med. 2004;45:1004–1028
  6. Maurer A. Consensus report on gastric emptying: What's needed to prevent tarnishing a gold standard?. J Nucl Med. 2008;49:339
  7. Maurer AH, Parkman HP. Update on gastrointestinal scintigraphy. Semin Nucl Med. 2006;36:110–118
  8. Pandolfino JE, Kahrilas PJ. American Gastroenterological Association: AGA technical review on the clinical use of esophageal manometry. Gastroenterology. 2005;128:209–224
  9. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: A technical review for practice guideline development. Gastroenterology. 1996;110:1982–1996
  10. Kahrilas PJ. Clinical practice (Gastroesophageal reflux disease). N Engl J Med. 2008;359:1700–1707
  11. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1392–1413
  12. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383–1391
  13. Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: A new clinically relevant classification by high-resolution manometry. Gastroenterology. 2008;135:1526–1533
  14. Hirano I, Pandolfino J. New technologies for the evaluation of esophageal motility disorders: Impedance, high-resolution manometry, and intraluminal ultrasound. Gastroenterol Clin North Am. 2007;36:531–551
  15. Savarino V, Pace F. Innovations in oesophageal function testing. Dig Liver Dis. 2008;40:153–155
  16. Kazem I. A new scintigraphic technique for the study of the esophagus. Am J Roentgenol Radium Ther Nucl Med. 1972;115:681–688
  17. Klein HA. Esophageal transit scintigraphy. Semin Nucl Med. 1995;25:306–317
  18. McCann J. Esophageal cancers: Changing character, increasing incidence. J Natl Cancer Inst. 1999;91:497–498
  19. Stacey B, Patel P. Oesophageal scintigraphy for the investigation of dysphagia: in and out of favour—underused when available. Eur J Nucl Med Mol Imaging. 2002;29:1216–1220
  20. Ebert EC. Esophageal disease in scleroderma. J Clin Gastroenterol. 2006;40:769–775
  21. Geatti O, Shapiro B, Fig LM, et al. Radiolabelled semisolid test meal clearance in the evaluation of esophageal involvement in scleroderma and Sjogren's syndrome. Am J Physiol Imaging. 1991;6:65–73
  22. Parkman HP, Maurer AH, Caroline DF, et al. Optimal evaluation of patients with nonobstructive esophageal dysphagia (Manometry, scintigraphy, or videoesophagography?). Dig Dis Sci. 1996;41:1355–1368
  23. Mughal MM, Marples M, Bancewicz J. Scintigraphic assessment of oesophageal motility: What does it show and how reliable is it?. Gut. 1986;27:946–953
  24. Tatsch K, Voderholzer WA, Weiss MJ, et al. Reappraisal of quantitative esophageal scintigraphy by optimizing results with ROC analyses. J Nucl Med. 1996;37:1799–1805
  25. Gelfond M, Rozen P, Gilat T. Isosorbide dinitrate and nifedipine treatment of achalasia: A clinical manometric and radionuclide evaluation. Gastroenterology. 1982;83:963–969
  26. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127:1592–1622
  27. Parkman HP, Schwartz SS. Esophagitis and gastroduodenal disorders associated with diabetic gastroparesis. Arch Intern Med. 1987;147:1477–1480
  28. Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care. 1999;22:503–507
  29. Irvine EJ, Tougas G, Lappalainen R, et al. Reliability and interobserver variability of ultrasonographic measurement of gastric emptying rate. Dig Dis Sci. 1993;38:803–810
  30. Kusunoki H, Haruma K, Hata J, et al. Real-time ultrasonographic assessment of antroduodenal motility after ingestion of solid and liquid meals by patients with functional dyspepsia. J Gastroenterol Hepatol. 2000;15:1022–1027
  31. Schwizer W, Maecke H, Fried M. Measurement of gastric emptying by magnetic resonance imaging in humans. Gastroenterology. 1992;103:369–376
  32. Kunz P, Feinle-Bisset C, Faas H, et al. Effect of ingestion order of the fat component of a solid meal on intragastric fat distribution and gastric emptying assessed by MRI. J Magn Reson Imaging. 2005;21:383–390
  33. Camilleri M, Zinsmeister AR, Greydanus MP, et al. Towards a less costly but accurate test of gastric emptying and small bowel transit. Dig Dis Sci. 1991;36:609–615
  34. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: Establishment of international control values. Am J Gastroenterol. 2000;95:1456–1462
  35. Ziessman HA, Bonta DV, Goetze S, et al. Experience with a simplified, standardized 4-hour gastric emptying protocol. J Nucl Med. 2007;48:568–572
  36. Guo JP, Maurer AH, Fisher RS, et al. Extending gastric emptying scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci. 2001;46:24–29
  37. Chaudhuri TK, Fink S. Gastric emptying in human disease states. Am J Gastroenterol. 1991;86:533–538
  38. Couturier O, Bodet-Milin C, Querellou S, et al. Gastric scintigraphy with a liquid-solid radiolabelled meal: Performances of solid and liquid parameters. Nucl Med Commun. 2004;25:1143–1150
  39. Camilleri M, Malagelada JR, Brown ML, et al. Relation between antral motility and gastric emptying of solids and liquids in humans. Am J Physiol. 1985;249:G580–G585
  40. Siegel JA, Urbain JL, Adler LP, et al. Biphasic nature of gastric emptying. Gut. 1988;29:85–89
  41. Elashoff JD, Reedy TJ, Meyer JH. Analysis of gastric emptying data. Gastroenterology. 1982;83:1306–1312
  42. Choi MG, Camilleri M, Burton DD, et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol. 1998;93:92–98
  43. Cremonini F, Mullan BP, Camilleri M, et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002;16:1781–1790
  44. Fraser R, Horowitz M, Maddox A, et al. Dual effects of cisapride on gastric emptying and antropyloroduodenal motility. Am J Physiol. 1993;264:G195–G201
  45. Fraser RJ, Horowitz M, Maddox AF, et al. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis–effects of cisapride. Gut. 1994;35:172–178
  46. Lyday WD, DiBaise JK. Metoclopramide-stimulated gastric emptying scintigraphy: Does it predict symptom response to prokinetic therapy in chronic gastroparesis?. Am J Gastroenterol. 2002;97:2474–2476
  47. Fajardo NR, Cremonini F, Talley NJ. Frontiers in functional dyspepsia. Curr Gastroenterol Rep. 2005;7:289–296
  48. Lawal A, Barboi A, Krasnow A, et al. Rapid gastric emptying is more common than gastroparesis in patients with autonomic dysfunction. Am J Gastroenterol. 2007;102:618–623
  49. Samsom M, Vermeijden JR, Smout AJ, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: A prospective study in unselected diabetic patients. Diabetes Care. 2003;26:3116–3122
  50. Urbain JL, Van Cutsem E, Siegel JA, et al. Visualization and characterization of gastric contractions using a radionuclide technique. Am J Physiol. 1990;259:G1062–G1067
  51. Linke R, Meier M, Muenzing W, et al. Prokinetic therapy: What can be measured by gastric scintigraphy?. Nucl Med Comm. 2005;26:527–533
  52. Tack J, Piessevaux H, Coulie B, et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115:1346–1352
  53. Kim DY, Myung SJ, Camilleri M. Novel testing of human gastric motor and sensory functions: Rationale, methods, and potential applications in clinical practice. Am J Gastroenterol. 2000;95:3365–3373
  54. de Zwart IM, Haans JJ, Verbeek P, et al. Gastric accommodation and motility are influenced by the barostat device: Assessment with magnetic resonance imaging. Am J Physiol. 2007;292:G208–G214
  55. Schwizer W, Steingötter A, Fox M, et al. Noninvasive measurement of gastric accommodation in humans. Gut. 2002;51(suppl 1):i59–i62
  56. Fruehauf H, Goetze O, Steingoetter A, et al. Intersubject and intrasubject variability of gastric volumes in response to isocaloric liquid meals in functional dyspepsia and health. Neurogastroenterol Motil. 2007;19:553–561
  57. Bharucha AE, Fidler J, Camilleri M, et al. Comparison of gastric volumes measured by MRI and SPECT. Neurogastroenterol Motil. 2007;19:421–422
  58. Gilja OH, Lunding J, Hausken T, et al. Gastric accommodation assessed by ultrasonography. World J Gastroenterol. 2006;12:2825–2829
  59. Manini ML, Burton DD, Meixner DD, et al: Feasibility and application of 3-dimensional ultrasound for measurement of gastric volumes in healthy adults and adolescents. J Pediatr Gastroenterol Nutr (in press)
  60. Bredenoord AJ, Chial HJ, Camilleri M, et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol. 2003;1:264–272
  61. Kuiken SD, Samsom M, Camilleri M, et al. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999;277:G1217–G1221
  62. Bouras EP, Delgado-Aros S, Camilleri M, et al. SPECT imaging of the stomach: Comparison with barostat, and effects of sex, age, body mass index, and fundoplication (Single photon emission computed tomography). Gut. 2002;51:781–786
  63. De Schepper H, Camilleri M, Cremonini F, et al. Comparison of gastric volumes in response to isocaloric liquid and mixed meals in humans. Neurogastroenterol Motil. 2004;16:567–573
  64. van den Elzen BD, Bennink RJ, Wieringa RE, et al. Fundic accommodation assessed by SPECT scanning: Comparison with the gastric barostat. Gut. 2003;52:1548–1554
  65. Simonian HP, Maurer AH, Knight LC, et al. Simultaneous assessment of gastric accommodation and emptying: Studies with liquid and solid meals. J Nucl Med. 2004;45:1155–1160
  66. Burton DD, Kim HJ, Camilleri M, et al. Relationship of gastric emptying and volume changes after a solid meal in humans. Am J Physiol. 2005;289:G261–G266
  67. Argenyi EE, Soffer EE, Madsen MT, et al. Scintigraphic evaluation of small bowel transit in healthy subjects: Inter- and intrasubject variability. Am J Gastroenterol. 1995;90:938–942
  68. Miller MA, Parkman HP, Urbain JL, et al. Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: Lactulose accelerates small bowel transit. Dig Dis Sci. 1997;42:10–18
  69. Charles F, Camilleri M, Phillips SF, et al. Scintigraphy of the whole gut: Clinical evaluation of transit disorders. Mayo Clin Proc. 1995;70:113–118
  70. Camilleri M, Zinsmeister AR. Towards a relatively inexpensive, noninvasive, accurate test for colonic motility disorders. Gastroenterology. 1992;103:36–42
  71. Cremonini F, Mullan BP, Camilleri M, et al. Performance characteristics of scintigraphic transit measurements for studies of experimental therapies. Aliment Pharmacol Ther. 2002;16:1781–1790
  72. Shah ND, Chitkara DK, Locke GR, et al. Ambulatory care for constipation in the United States, 1993-2004. Am J Gastroenterol. 2008;103:1746–1753
  73. Choung RS, Locke GR, Schleck CD, et al. Cumulative incidence of chronic constipation: A population-based study 1988-2003. Aliment Pharmacol Ther. 2007;26:1521–1528
  74. Arhan P, Devroede G, Jehannin B, et al. Segmental colonic transit time. Dis Colon Rectum. 1981;24:625–629
  75. Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colonic transit. Gastroenterology. 1987;92:40–47
  76. Sadik R, Stotzer PO, Simrén M, et al. Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre. Neurogastroenterol Motil. 2008;20:197–205
  77. Proano M, Camilleri M, Phillips SF, et al. Transit of solids through the human colon: Regional quantification in the unprepared bowel. Am J Physiol. 1990;258:G856–G862
  78. Burton DD, Camilleri M, Mullan BP, et al. Colonic transit scintigraphy labeled activated charcoal compared with ion exchange pellets. J Nucl Med. 1997;38:1807–1810
  79. Bonapace ES, Maurer AH, Davidoff S, et al. Whole gut transit scintigraphy in the clinical evaluation of patients with upper and lower gastrointestinal symptoms. Am J Gastroenterol. 2000;95:2838–2847
  80. von der Ohe MR, Camilleri M, Kvols LK, et al. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. N Engl J Med. 1993;329:1073–1078
  81. Camilleri M, McKinzie S, Busciglio I, et al. Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2008;6:772–781
  82. Kamm MA, Lennard-Jones JE, Thompson DG, et al. Dynamic scanning defines a colonic defect in severe idiopathic constipation. Gut. 1988;29:1085–1092
  83. Bharucha AE, Low PA, Camilleri M, et al. Pilot study of pyridostigmine in constipated patients with autonomic neuropathy. Clin Auton Res. 2008;18:194–202
  84. Bharucha AE, Fletcher JG, Seide B, et al. Phenotypic variation in functional disorders of defecation. Gastroenterology. 2005;128:1199–1210
  85. Hoyte L, Jakab M, Warfield SK, et al. Levator ani thickness variations in symptomatic and asymptomatic women using magnetic resonance-based 3-dimensional color mapping. Am J Obstet Gynecol. 2004;191:856–861
  86. Gearhart SL, Pannu HK, Cundiff GW, et al. Perineal descent and levator ani hernia: A dynamic magnetic resonance imaging study. Dis Colon Rectum. 2004;47:1298–1304
  87. Pezim ME, Pemberton JH, Levin KE, et al. Parameters of anorectal and colonic motility in health and in severe constipation. Dis Colon Rectum. 1993;36:484–891
  88. Barkel DC, Pemberton JH, Pezim ME, et al. Scintigraphic assessment of the anorectal angle in health and after ileal pouch-anal anastomosis. Ann Surg. 1988;208:42–49
  89. Wald A, Jafri F, Rehder J, et al. Scintigraphic studies of rectal emptying in patients with constipation and defecatory difficulty. Dig Dis Sci. 1993;38:353–358
  90. Harewood GC, Coulie B, Camilleri M, Rath-Harvey D, Pemberton JH. Descending perineum syndrome: audit of clinical and laboratory features and outcome of pelvic floor retraining. Am J Gastroenterol. 1999;94:126–130
  91. Houghton LA, Foster JM, Whorwell PJ. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther. 2000;14:775–782
  92. Viramontes BE, Camilleri M, McKinzie S, et al. Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2001;96:2671–2676
  93. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology. 2000;118:463–468
  94. Camilleri M, McKinzie S, Fox J, et al. Effect of renzapride on transit in constipation-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2:895–904
  95. Tack J, Middleton SJ, Horne MC, et al. Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2006;23:1655–1665
  96. Andresen V, Camilleri M, Busciglio IA, et al. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome. Gastroenterology. 2007;133:761–768
  97. Kim HJ, Camilleri M, McKinzie S, et al. A randomized controlled trial of a probiotic, VSL #3, on gut transit and symptoms. Aliment Pharmacol Ther. 2003;17:895–904
  98. Bouras EP, Camilleri M, Burton DD, et al. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Gastroenterology. 2001;120:354–360
  99. Camilleri M, Bharucha AE, Ueno R, et al. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol. 2006;290:G942–G947

 Funded in part by grants RO1 DK 67071 and K24 DK 02638 from the National Institutes of Health (to M.C.).

PII: S0001-2998(08)00136-0

doi: 10.1053/j.semnuclmed.2008.11.002

Seminars in Nuclear Medicine
Volume 39, Issue 3 , Pages 186-194 , May 2009

Article Tools

* Image Usage & Resolution